ES2116421T3 - Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente. - Google Patents
Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente.Info
- Publication number
- ES2116421T3 ES2116421T3 ES93402135T ES93402135T ES2116421T3 ES 2116421 T3 ES2116421 T3 ES 2116421T3 ES 93402135 T ES93402135 T ES 93402135T ES 93402135 T ES93402135 T ES 93402135T ES 2116421 T3 ES2116421 T3 ES 2116421T3
- Authority
- ES
- Spain
- Prior art keywords
- insulin
- treatment
- amino acids
- compositions containing
- dependent diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
COMPOSICION ANTIDIABETICA, CARACTERIZADA PORQUE CONTIENE COMO SUSTANCIA ACTIVA, EN ESTADO LIBRE O COMBINADO, AL MENOS UN ACIDO AMINO MONO O POLIHIDROXILADO Y/O SUS FORMAS LACTONICAS Y SUS DERIVADOS CON AMIDAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9210644A FR2695317B1 (fr) | 1992-09-07 | 1992-09-07 | Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2116421T3 true ES2116421T3 (es) | 1998-07-16 |
Family
ID=9433260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93402135T Expired - Lifetime ES2116421T3 (es) | 1992-09-07 | 1993-09-01 | Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5470879A (es) |
EP (1) | EP0587476B1 (es) |
JP (1) | JP2655044B2 (es) |
AT (1) | ATE164064T1 (es) |
CA (1) | CA2105502C (es) |
DE (1) | DE69317494T2 (es) |
DK (1) | DK0587476T3 (es) |
ES (1) | ES2116421T3 (es) |
FR (1) | FR2695317B1 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2745718B1 (fr) * | 1996-03-08 | 1998-05-07 | Gestion Jouvenet Soc Civ De | Composition antidiabetique a base de 4-hydroxyisoleucine |
US6042834A (en) * | 1997-01-29 | 2000-03-28 | Baraka; Mohamed Wasif | Herbal composition for diabetes and method of treatment |
AU6576398A (en) * | 1997-03-24 | 1998-10-20 | Galderma Research & Development, S.N.C. | Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus |
FR2797767B1 (fr) * | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
US6939933B2 (en) * | 2000-12-20 | 2005-09-06 | Exxonmobil Chemical Patents Inc. | Process for polymerizing cationically polymerizable monomers |
CN100475757C (zh) * | 2000-02-01 | 2009-04-08 | 斯特维亚私人有限公司 | 用于饮食补充或用于制备治疗非胰岛素依赖性糖尿病、高血压和/或代谢综合征的药物的物质 |
US6329167B1 (en) * | 2000-12-05 | 2001-12-11 | Bruce K. Patterson | Method of testing adequacy of cells in a specimen |
US6551627B1 (en) * | 2001-05-03 | 2003-04-22 | Holomed Pharmaceuticals, Ltd. | Medicinal herbal compounds for the prevention and treatment of diabetes |
US6903136B2 (en) * | 2002-04-22 | 2005-06-07 | Experimental And Applied Sciences, Inc. | Food supplements containing 4-hydroxyisoleucine and creatine |
US7338675B2 (en) * | 2002-05-10 | 2008-03-04 | Tsi Health Sciences, Inc. | Fenugreek seed bio-active compositions and methods for extracting same |
US20050176827A1 (en) * | 2002-05-10 | 2005-08-11 | Lee Steve S. | Compositions and methods for glycogen synthesis |
CN100415224C (zh) * | 2003-03-18 | 2008-09-03 | 诺瓦提斯公司 | 包含脂肪酸和氨基酸的组合物 |
FR2852841B1 (fr) * | 2003-03-28 | 2006-08-04 | Vincience | Composition cosmetique ou pharmaceutique comprenant des acides amines, utilisations et procedes de traitement |
US7736676B2 (en) * | 2003-05-14 | 2010-06-15 | Indus Biotech Pvt. Ltd. | Synergistic composition for the treatment of diabetes mellitus |
US7674486B2 (en) * | 2003-05-14 | 2010-03-09 | Indus Biotech Pvt. Ltd. | Synergistic composition for the treatment of diabetes mellitus |
DK1638586T3 (da) * | 2003-05-14 | 2008-06-23 | Indus Biotech Pvt Ltd | Synergistisk sammensætning til behandling af diabetes mellitus |
FR2856297B1 (fr) * | 2003-06-18 | 2005-08-05 | Caster | Utilisation de (2s,3r,4s)-4-hydroxyisoleucine dans des compositions cosmetiques pour application topique |
US20070004623A1 (en) * | 2003-10-27 | 2007-01-04 | Innodia Inc. | Use of hydroxylated amino acids for treating diabetes |
CN1313435C (zh) * | 2003-10-27 | 2007-05-02 | 成都华高药业有限公司 | 一种从葫芦巴中提取4-羟基异亮氨酸制品的新方法 |
GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
US20080182801A1 (en) * | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
US20050233014A1 (en) * | 2004-03-02 | 2005-10-20 | Lee Steve S | Methods for affecting homeostasis and metabolism in a mammalian body |
US20050226948A1 (en) * | 2004-03-02 | 2005-10-13 | Lee Steve S | Methods for enhancing the transport of glucose into muscle |
US7645466B2 (en) | 2004-03-02 | 2010-01-12 | Tsi Group Limited | Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seed |
US20050233013A1 (en) * | 2004-03-02 | 2005-10-20 | Lee Steve S | Methods for enhancing the transport of glucose for balancing blood sugar levels |
US20090076111A1 (en) * | 2004-03-02 | 2009-03-19 | Lee Steve S | Methods for improving glycemic control in humans |
CN101193852A (zh) * | 2005-02-18 | 2008-06-04 | 因诺迪亚有限公司 | 4-羟基异亮氨酸类似物及其用途 |
WO2006131836A2 (en) * | 2005-03-22 | 2006-12-14 | Innodia Inc. | Compounds and compositions for use in the prevention and treatment of obesity and related syndromes |
GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
FR2887773B1 (fr) * | 2005-07-01 | 2008-05-30 | Soc Extraction Principes Actif | Utilisation d'un acide amine en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau. |
GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
WO2007107008A1 (en) * | 2006-03-22 | 2007-09-27 | Innodia Inc. | Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
EP2123629A1 (en) * | 2007-02-22 | 2009-11-25 | Ajinomoto Co., Inc. | Method for purifying 4-hydroxyisoleucine |
RU2395580C2 (ru) | 2007-12-21 | 2010-07-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО АГРИ) | Способ конструирования бактерии-продуцента (2s,3r,4s)-4-гидрокси-l-изолейцина, бактерия-продуцент (2s,3r,4s)-4-гидрокси-l-изолейцина и способ продукции (2s,3r,4s)-гидрокси-l-изолейцина или его соли |
EA028836B1 (ru) | 2009-08-12 | 2018-01-31 | Мунисекхар Медасани | Натуральный экстракт из цельных плодов банана (musa spp.) |
WO2011021717A2 (en) | 2009-08-21 | 2011-02-24 | Ajinomoto Co.,Inc. | Method for producing hydroxylated amino acids |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2315916A2 (fr) * | 1976-03-23 | 1977-01-28 | Univ Johns Hopkins | Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree |
US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
-
1992
- 1992-09-07 FR FR9210644A patent/FR2695317B1/fr not_active Expired - Fee Related
-
1993
- 1993-09-01 EP EP93402135A patent/EP0587476B1/fr not_active Expired - Lifetime
- 1993-09-01 DK DK93402135T patent/DK0587476T3/da active
- 1993-09-01 AT AT93402135T patent/ATE164064T1/de not_active IP Right Cessation
- 1993-09-01 ES ES93402135T patent/ES2116421T3/es not_active Expired - Lifetime
- 1993-09-01 DE DE69317494T patent/DE69317494T2/de not_active Expired - Fee Related
- 1993-09-01 JP JP5217588A patent/JP2655044B2/ja not_active Expired - Fee Related
- 1993-09-03 CA CA002105502A patent/CA2105502C/fr not_active Expired - Fee Related
-
1994
- 1994-12-23 US US08/364,079 patent/US5470879A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0587476A1 (fr) | 1994-03-16 |
ATE164064T1 (de) | 1998-04-15 |
JP2655044B2 (ja) | 1997-09-17 |
DE69317494D1 (de) | 1998-04-23 |
US5470879A (en) | 1995-11-28 |
CA2105502C (fr) | 2000-11-21 |
FR2695317B1 (fr) | 1995-03-10 |
DK0587476T3 (da) | 1998-12-07 |
JPH06157302A (ja) | 1994-06-03 |
EP0587476B1 (fr) | 1998-03-18 |
FR2695317A1 (fr) | 1994-03-11 |
CA2105502A1 (fr) | 1994-03-08 |
DE69317494T2 (de) | 1998-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2116421T3 (es) | Composiciones que contienen aminoacidos mono o polihidroxilados para el tratamiento de la diabetes no insulino-dependiente. | |
FI950697A (fi) | IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan | |
DE59306544D1 (de) | Verwendungen von alpha-Hydroxyfettsäuren | |
TR199800019T1 (xx) | Trombosit topaklanmas�n� �nleyici yeni maddeler. | |
ATE133534T1 (de) | Antimikrobizides gemisch | |
ES2065701T3 (es) | Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas. | |
BR9100938A (pt) | Composicao que compreende um inibidor de elastase,derivados de 1-dioxido de benzisotiazolinona e processo para tratamento com cosmetico | |
ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
ES2102878T3 (es) | Oxatiazinas conservantes de madera. | |
ES2062375T3 (es) | Composiciones farmaceuticas que contienen un complejo de zinc. | |
DE69311541T2 (de) | Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten | |
DE60225143D1 (de) | Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes | |
BR9810567A (pt) | Composições antimicrobianas sinérgicas contendo uma dimetilamida de um ácido carboxìlico com uma mistura de 2-(tiocianometiltio) benzotiazol e um metileno-bis (tiocianato) e uso destes | |
SE8600658D0 (sv) | Novel composition of matter | |
DE69104083D1 (de) | Neue Antiulcus-Substanz. | |
ATE274904T1 (de) | 4,5-dihydroxy-2-cyclopenten-1-on für die behandlung von diabetes mellitus | |
MX170055B (es) | , "composicion insecticida y procedimiento para su obtencion | |
MX9305523A (es) | Composiciones quimoterapeuticas mejoradas frente a infecciones microbianas en peces, la reparacion y uso de las mismas. | |
DE69936190D1 (de) | Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels | |
RU94028126A (ru) | Средство, обладающее иммуномодулирующей активностью | |
ES2126015T3 (es) | Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas. | |
ES2106689B1 (es) | Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea. | |
HK1005063A1 (en) | Pharmaceutical compositions containing 1- oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes | |
KR880012228A (ko) | 천식 치료제 | |
GT199300041A (es) | Derivados de hidrazona, proceso para producir los mismos, insecticidas y/o acaricidas que contienen dichos derivados co-mo ingrediente activo y compuestos intermedios para producir dichos derivados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 587476 Country of ref document: ES |